Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis
✍ Scribed by Fei Mao; Wen-Rong Xu; Hui Qian; Wei Zhu; Yong-Min Yan; Qi-Xiang Shao; Hua-Xi Xu
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 2009
- Tongue
- English
- Weight
- 331 KB
- Volume
- 59
- Category
- Article
- ISSN
- 1420-908X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Mesenchymal stem cells (MSCs) are precursors of tissue of mesenchymal origin, but they also have the capacity to regulate the immune response by suppressing T and B lymphocyte proliferation in a non–major histocompatibility complex–restricted manner. Use of MSCs as immunos
## Abstract Many cell types and cellular microenvironments have been explored for articular cartilage tissue engineering. We compared the potential of bone marrow‐derived mesenchymal stem cells (MSCs) and P19 embryonic carcinoma cells (ECCs), a pluripotent derivative of embryonic stem cells (ESCs),
## Abstract Restenosis following vascular injury remains a pressing clinical problem. Mesenchymal stem cells (MSCs) promise as a main actor of cell‐based therapeutic strategies. The possible therapeutic role of MSCs in vascular stenosis in vivo has been poorly investigated so far. We tested the eff
## Abstract Mesenchymal stem cells (MSCs) have a great therapeutic potential resulting from their ability to differentiate into multiple tissues when cultured under specific conditions. However, it has not been clearly demonstrated whether or not MSCs exhibit a multidifferentiation potential in thr
## Abstract The chondrogenic differentiation of bone marrow‐derived human mesenchymal stem cells (MSCs) in a collagen type I hydrogel, which is in clinical use for matrix‐based autologous chondrocyte transplantation (ACT), was investigated. Collagen hydrogels with 2.5 × 10^5^ MSCs/mL were fabricate